Abstract:There is large interest in the early diagnosis of Alzheimer's disease (AD) using machine learning. The NIH-sponsored Alzheimer's Disease Connectome Project (ADCP), a multi-center MRI, PET, and behavioral study of brain connectivity in AD, has a specific aim of accurately staging AD throughout its progression on an individual basis. It uses state-of-the-art MRI imaging techniques which allow for building reliable machine learning models. In this ongoing project, we are training models with the MRI structural brain features to separate between healthy controls and a group of AD and mild cognitive impairment (MCI) patients. Data from 12 patients (age=70.8±6.6 years, 7 males, 4 AD patients), and 20 healthy controls (age=68.9±6.2 years, 11 males), enrolled in ADCP, were analyzed. The two groups matched in age (p=0.45) and gender ratio (p=0.85). All images were acquired with 3T GE 750 scanners. T1-weighted images were acquired using a magnetization prepared gradient echo sequence (TR/TE=604ms/2.516ms, 0.8mm isotropic). Data were pre-processed using FreeSurfer-based Human Connectome Project (HCP) processing pipelines. 269 structural features were extracted, which include cortical thicknesses, surface areas, and subcortical and global volumes. They were normalized with the individual intracranial volume and then with the standardized z-score transform. 3 traditional binary classification machine learning models were trained in Matlab: support vector machine (SVM), linear discriminant analysis (LDA), and naïve Bayes (NB) classifiers. We applied a t-test based filter selection method, where only a group of features with the largest group mean differences in the training set enters the training. For performance estimation, we used leave-one-out cross validation (LOOCV) and the area-under-the-curve (AUC). SVM model classified the two groups with 90.6% accuracy (sensitivity=83.3%, specificity=95.0%, AUC=0.78, 23 features). NB model reached 84.38% (sensitivity=83.3%, specificity=85.0%, AUC=0.83, 10 features). Bilateral temporal pole volumes and right entorhinal volume were the most discriminating features. Linear traditional machine learning models were able to separate between AD/MCI patients and healthy controls with mid-80 to 90% accuracy. This is promising as it is known that non-linear, deep learning methods will outperform these traditional models given more data in the future. Building an automated model to classify Alzheimer's patients is expected to aid early diagnosis . A t-test based filter selection method was used to let only a certain number of features with the most group difference to be used in the training. SVM reached the highest LOOCV accuracy at 90.6% using 23 features. Bilateral temporal pole volumes showed the most group differences and helped machine learning separate the two groups. The volumes are noticeably reduced in MCI and AD patients compared to the healthy controls.

Learning the progression and clinical subtypes of Alzheimer's disease from longitudinal clinical data

Machine learning on longitudinal multi-modal data enabling the understanding and prognosis of Alzheimer’s disease progression

Machine learning on longitudinal multi-modal data enables the understanding and prognosis of Alzheimer's disease progression

Characterizing the clinical heterogeneity of early symptomatic Alzheimer's disease: a data-driven machine learning approach

Identification of Outcome-Oriented Progression Subtypes from Mild Cognitive Impairment to Alzheimer’s Disease Using Electronic Health Records

Learning the irreversible progression trajectory of Alzheimer's disease

Disentangling brain heterogeneity via semi‐supervised deep‐learning and MRI: Application to dimensional representations of Alzheimer’s disease

CHARACTERIZING STRUCTURAL BRAIN ALTERATIONS IN ALZHEIMER’S DISEASE PATIENTS WITH MACHINE LEARNING

Machine learning for modeling the progression of Alzheimer disease dementia using clinical data: a systematic literature review

Identifying and evaluating clinical subtypes of Alzheimer’s disease in care electronic health records using unsupervised machine learning

Towards Alzheimer's Disease Progression Assessment: A Review of Machine Learning Methods

Longitudinal Volumetric Study for the Progression of Alzheimer's Disease from Structural MRI

DeepAD: A Robust Deep Learning Model of Alzheimer's Disease Progression for Real-World Clinical Applications

Current Understanding of Alzheimer's Disease on Biomarkers, Magnetic Resonance Imaging Modalities, and Diagnosis, Prevention, and Treatment Approach

Synthetic data analysis for early detection of Alzheimer progression through machine learning algorithms

Prediction and clustering of Alzheimer's disease by race and sex: a multi-head deep-learning approach to analyze irregular and heterogeneous data

High-Order Multi-Task Feature Learning to Identify Longitudinal Phenotypic Markers for Alzheimer's Disease Progression Prediction.

Using Multi-Scale Genetic, Neuroimaging and Clinical Data for Predicting Alzheimer’s Disease and Reconstruction of Relevant Biological Mechanisms

Early-Stage Alzheimer's Disease Prediction Using Machine Learning Models

A DEEP LEARNING-BASED FRAMEWORK FOR ALZHEIMER'S DISEASE DIAGNOSIS AND PROGRESSION PREDICTION FROM MRI IMAGES

Rethinking modeling Alzheimer's disease progression from a multi-task learning perspective with deep recurrent neural network